Correlation Engine 2.0
Clear Search sequence regions

  • adalimumab (6)
  • case (1)
  • case report (1)
  • corticosteroids (1)
  • hemophilia (4)
  • humans (1)
  • patient (2)
  • rituximab (3)
  • scleritis (3)
  • Sizes of these terms reflect their relevance to your search.

    Acquired hemophilia A (AHA) is a rare condition that may be drug-induced. In this case report, we describe a patient who presented with extensive subcutaneous bleeding three years after beginning treatment with adalimumab for necrotizing scleritis. His workup was compatible with drug-induced AHA. He was treated with high-dose corticosteroids, cyclophosphamide, and rituximab. Adalimumab was discontinued. We present this case as an example of a rare, but potentially life-threatening, complication of adalimumab.


    Paulina Liberman, Bryn M Burkholder. Adalimumab-associated Acquired Hemophilia in a Patient with Scleritis. Ocular immunology and inflammation. 2022 Feb 17;30(2):294-296

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32966141

    View Full Text